Evidence map›Paper›PMID 31706301›Full record

ArticleBMC veterinary research2019

Simultaneous evaluation of diagnostic marker utility for enzootic bovine leukosis.

Misako Konishi, Sota Kobayashi, Taeko Tokunaga, Yuzumi Chiba, Toshiyuki Tsutsui, Shozo Arai, Ken-Ichiro Kameyama, Takehisa Yamamoto

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Misako KonishiEpidemiology Unit, Division of Viral Disease and Epidemiology, National Institute of Animal Health, NARO 3-1-5 Kannondai, Tsukuba, Ibaraki, 305-0856, Japan.
Sota KobayashiParasitic Disease Unit, Division of Bacterial and Parasitic Disease, National Institute of Animal Health, NARO 3-1-5 Kannondai, Tsukuba, Ibaraki, 305-0856, Japan.
Taeko TokunagaKumamoto Meat Inspection Office, 1341, Shichijomachisosaki, Kikuchi, Kumamoto, Kumamoto, 861-1344, Japan.
Yuzumi ChibaIwate Prefecture Central Livestock Hygiene Service Center, 390-5 Sunagome, Takizawa, Iwate, 020-0605, Japan.
Toshiyuki TsutsuiDirector-General, National Institute of Animal Health, NARO 3-1-5 Kannondai, Tsukuba, Ibaraki, 305-0856, Japan.
Shozo AraiClinical Biochemistry Unit, Division of Pathology and Pathophysiology, National Institute of Animal Health, NARO 3-1-5 Kannondai, Tsukuba, Ibaraki, 305-0856, Japan.
Ken-Ichiro KameyamaNational Institute of Animal Health, NARO, Exotic Diseases Research Station Josuihoncho, Kodaira, Tokyo, 187-0022, Japan.
Takehisa YamamotoEpidemiology Unit, Division of Viral Disease and Epidemiology, National Institute of Animal Health, NARO 3-1-5 Kannondai, Tsukuba, Ibaraki, 305-0856, Japan. mtbook@affrc.go.jp.ORCID http://orcid.org/0000-0002-8707-0639
National Institute of Animal Health · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnzootic bovine leukosis (EBL) is a disease of cattle caused by bovine leukemia virus (BLV). More than 60% of BLV-infected cattle remain subclinical and are thus referred to as aleukemic (AL) cattle. Approximately 30% of infected cattle show a relatively stable increase in the number of B lymphocytes; these cattle are termed persistent lymphocytosis (PL) cattle. A small percentage of infected cattle develop BLV-induced B cell lymphoma (EBL) and are called EBL cattle. Due to the increase in the number of BLV-infected cattle, the number of EBL cattle has featured a corresponding increase over recent years in Japan. Several diagnostic criteria for EBL (e.g., enlarged superficial lymph nodes, protrusion of the eye, increased peripheral blood lymphocyte, etc.) are used for on-farm diagnosis and antemortem tests at slaughterhouses. Since the slaughter of EBL cattle for human consumption is not allowed, on-farm detection of EBL cattle is important for reducing the economic loss incurred by farms. Therefore, establishing new diagnostic markers to improve the efficiency and accuracy of the antemortem detection of EBL cattle is a critical, unmet need. To simultaneously evaluate the utility of candidate markers, this study measured the values of each marker using the blood samples of 687 cattle with various clinical statuses of BLV infection (EBL, PL, AL and non-infected cattle).

resultsSensitivity (Se) and specificity (Sp) were highest for the serum thymidine kinase (TK) followed by the serum lactate dehydrogenase (LDH) isozyme 2. The number of peripheral blood lymphocytes and proviral load in peripheral blood had the lowest Se and Sp. The values of all markers other than TK were influenced by the sex of the tested cattle.

conclusionsAlthough tLDH and its isozymes (LDHs) may be influenced by the sex of the tested cattle, the high accuracy of TK and LDH2 as well as accessibility and simplicity of the protocol used to measure these enzymes recommend the utility of TK and LDHs for EBL cattle detection. Using these markers for screening followed by the application of existing diagnostic criteria may improve the efficiency and accuracy of EBL cattle detection on farms, thereby contributing to the reduction of economic losses in farms.

Indexed as

AnimalsBiomarkersB-LymphocytesCattleEnzootic Bovine LeukosisFemaleIsoenzymesLeukemia Virus, BovineLeukocyte CountL-Lactate DehydrogenaseLymphoma, B-CellMaleSensitivity and SpecificityThymidine KinaseBiomarkersIsoenzymesL-Lactate DehydrogenaseThymidine KinaseBiomarkerCattleEnzootic bovine leukosisLactate dehydrogenaseThymidine kinase

Identifiers

PMID31706301
PMCPMC6842470
OpenAlexW2983929859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.